Exchange: PRIVATE·

NITENightstar Therapeutics PLC

$0.00
$0.00
(0.00%)
Today
News
all
press releases
ETFs to Watch as Tesla Sees Worst Weekly Slump Post Q2 Earnings Miss
Tesla's post-earnings slump is likely to prompt some investors to consider diversified ETFs over direct exposure to the stock amid ongoing margin concerns.
Zacks
More News
Worried About Tesla's 7% Slump Post Solid Q2 Deliveries? Grab These ETFs
TSLA's shares slide 7.5% even after record Q2 deliveries, but ETFs may offer a diversified way to capture its long-term robotics potential.
Zacks
Should You Buy Alibaba ETFs as Stock Surges on AI Investment Push?
Alibaba shares surge on AI push, spotlighting ETF plays like ONLN, FNGS, PGJ and NITE. But is there margin pressure?
Zacks
Tesla ETFs: What's Next After Worst Q2 in a Decade?
TSLA posts worst quarterly revenue drop in over a decade, raising red flags for top Tesla-heavy ETFs like TESL, XLY, FDIS and VCR.
Zacks
Tesla ETFs in Focus Ahead of Q2 Earnings
XLY, TESL and other ETFs with heavy Tesla exposure could see big moves as TSLA readies its Q2 earnings report.
Zacks
Will Tesla's Worst-Ever Q2 Vehicle Sales Drop Shake its ETFs?
Tesla posts its steepest-ever delivery drop, yet its ETFs, such as TESL, XLY, VCR, NITE and FDIS, remain in focus amid increasing robotaxi ambitions.
Zacks
Time to Ride Tesla ETFs on Recent Stock Rebound & Robotaxi Launch?
Zacks
ETFs in Focus on Alibaba's Mixed Q4 Results
Zacks
<
1
>